BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25674238)

  • 1. Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patients.
    Jin Y; Yu Y; Shao Q; Ma Y; Zhang R; Yao H; Xu Y
    Int J Clin Exp Pathol; 2014; 7(12):8724-31. PubMed ID: 25674238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients.
    Wang HB; Yan HC; Liu Y
    Clin Transl Oncol; 2016 Jul; 18(7):735-42. PubMed ID: 26497353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
    Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY
    Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
    Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
    Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
    Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
    Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic significance of ECT2 in invasive breast cancer.
    Wang HK; Liang JF; Zheng HX; Xiao H
    J Clin Pathol; 2018 May; 71(5):442-445. PubMed ID: 29051317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer.
    Zhou B; Jing XY; Wu JQ; Xi HF; Lu GJ
    Int J Clin Exp Pathol; 2014; 7(12):8893-8. PubMed ID: 25674261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
    Hu X; Huang Z; Liao Z; He C; Fang X
    Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
    Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
    Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
    Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
    Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer.
    Guo Z; Chen X; Du T; Zhu D; Lai Y; Dong W; Wu W; Lin C; Liu L; Huang H
    Med Oncol; 2017 Jan; 34(1):13. PubMed ID: 28012134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C; Gao X; Liu H; Jiang T; Zhai X
    Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer.
    Luo Y; Qin SL; Mu YF; Wang ZS; Zhong M; Bian ZQ
    Biomed Pharmacother; 2015 Jul; 73():135-9. PubMed ID: 26211594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.